Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored vaccines that harness the full breadth of the immune system to protect ...

Karikó is the ninth Penn-affiliated recipient of the distinction, joining Judith Rodin and Amy Gutmann, former Penn ...

Two public companies focused on RNA editing therapies, Korro Bio and ProQR, enjoyed impressive stock surges powered by their best-ever one day gains; their share prices lifted by Wave Life Sciences ...

Recent research has unveiled shocking findings regarding the long-term health impacts of COVID-19 vaccinations, confirming concerns raised by various experts since the pandemic began. A peer-reviewed ...

New COVID-19 strains are emerging and with it the need for updated vaccines to protect people from the virus. So how do ...

We recently compiled a list of the 10 Best QQQ Stocks to Buy According to Analysts. In this article, we are going to take a ...

Scientists in Australia have found why mRNA vaccines trigger side effects, paving the way for more effective vaccines.

编者按：呼吸道合胞病毒（RSV）作为一种对婴幼儿及免疫功能不全人群构成重大威胁的呼吸道病原体，近年来其疫苗和单克隆抗体的研发取得了诸多进展。在刚结束的2024年美国感染性疾病周（IDWeek 2024）上，多项关于儿童RSV防治的最新研究成果备受瞩目 ...

Protects against variants: The COVID-19 vaccine also provides protection against new variants of the virus. Variants such as Delta and Omicron have spread rapidly, but studies have shown that vaccines ...